Case Report

Coinfection with SARS-CoV-2 and Cytomegalovirus in a Patient with Mild COVID-19

Table 2

Time course of CMV marker in the present case.

CMV markerDay 3Day 1 (admission)Day 4Day 8Day 14

CMV-IgM (CLIA)2.824.674.45
CMV IgG (CLIA)8.575.483.3
CMV antigenemia80/500004/500004/50000
CMV DNA (PCR)7800 IU/mL

CMV, cytomegalovirus; IgM, immunoglobulin M; CLIA, chemiluminescent immunoassay; IgG, immunoglobulin G; IgA, immunoglobulin A; DNA, deoxyribonucleic acid; PCR, polymerase chain reaction.